Breaking News Instant updates and real-time market news.

LGND

Ligand

$90.00

-2.87 (-3.09%)

16:03
01/13/20
01/13
16:03
01/13/20
16:03

Ligand enters into global OmniAb license agreement with Pandion

Ligand announces it has entered into a worldwide OmniAb license agreement with Pandion Therapeutics. Under the agreement, Pandion will be able to use Ligand's full OmniAb antibody discovery platform which includes OmniRat, OmniFlic, OmniMouse, OmniChicken and OmniClic. OmniAb is licensed to over 40 corporate partners globally, and this deal with Pandion adds to a growing portfolio of OmniAb discovery and clinical development programs. Pandion will pay Ligand an up-front platform access fee, development and regulatory milestone payments, and potential royalties on sales of marketed products. "This agreement provides Pandion access to the industry's only human immunoglobulin transgenic rats and chickens for efficient generation of mono- and bispecific antibody therapeutics," said John Higgins, CEO of Ligand.

  • 06

    Feb

LGND Ligand
$90.00

-2.87 (-3.09%)

09/19/19
LEHM
09/19/19
UPGRADE
Target $132
LEHM
Overweight
Ligand upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Balaji Prasad upgraded Ligand Pharmaceuticals to Overweight from Equal Weight and raised his price target for the shares to $132 from $110.
09/19/19
LEHM
09/19/19
UPGRADE
Target $132
LEHM
Overweight
Ligand upgraded to Overweight on pipeline potential at Barclays
As previously reported, Barclays analyst Balaji Prasad upgraded Ligand to Overweight from Equal Weight as he believes greater clarity on its pipeline offers strong support for its revenue potential and he revised his revenue forecasts for FY19-FY23 due to increased royalty estimates. The analyst pointed toward the upcoming sNDA for Baxdela IV in community-acquired bacterial pneumonia and Sparsentan topline Phase 3 data in FSGS, expected in the second half of 2020, as events to watch. Additionally, new Phase 3 data on Kyprolis + Darzalex may increase overall prescription levels, said Prasad, who also sees an improved risk/reward following the stock's recent underperformance compared to the NYSE ARCA Pharma Index. Prasad raised his price target for Ligand shares to $132 from $110.
09/19/19
09/19/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hyatt (H) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling saying the company is moving more aggressively towards asset light model, which should drive free cash flow and a re-rating in the shares. 2. Ligand (LGND) upgraded to Overweight from Equal Weight at Barclays with analyst Balaji Prasad saying he believes greater clarity on its pipeline offers strong support for its revenue potential and he revised his revenue forecasts for FY19-FY23 due to increased royalty estimates. 3. Twilio (TWLO) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Meta Marshall saying the company is building out a next-generation communication platform, with multiple expansion markets "still in their infancy." 4. KKR (KKR) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Alexander Blostein saying KKR is entering a period of accelerated earnings growth, driven by its upcoming fund-raising cycle and maturing investment portfolio, which should yield above-consensus incentive income and earnings. 5. Cousins Properties (CUZ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Blaine Heck saying the company's share underperformance year-to-date relative to peers is not warranted given its exposure to office markets that should see solid rent growth over the next 12-24 months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/20
HCWC
01/03/20
NO CHANGE
HCWC
Buy
Ligand royalties from Amgen may rise, but Novan hits bump, says H.C Wainwright
H.C. Wainwright analyst Joseph Pantginis noted that Ligand (LGND) partner Amgen (AMGN) announced the closing of its new 20.5% stake in BeiGene (BGNE) yesterday after the close, explaining that this could result in a likely bump up in Kyprolis royalty revenue as BeiGene is expected to commercialize Kyprolis in China over the next five to seven years. However, also after the close yesterday, another Ligand partner, Novan (NOVN), reported that the primary endpoint was missed in both studies testing SB206 in molloscum contagiosum patients. Until Novan gets FDA feedback about a potential path forward for SB206, he thinks investors will keep the program out of their estimates for Ligand's future revenue, said Pantginis. He maintains a Buy rating and $214 price target on Ligand shares.

TODAY'S FREE FLY STORIES

CTXS

Citrix

$119.45

1.66 (1.41%)

15:19
01/22/20
01/22
15:19
01/22/20
15:19
Options
Citrix options imply 7.2% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
01/22/20
01/22
15:17
01/22/20
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
01/22/20
01/22
15:16
01/22/20
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$72.03

-7.66 (-9.61%)

15:10
01/22/20
01/22
15:10
01/22/20
15:10
Recommendations
Blueprint Medicines analyst commentary  »

Amendment to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 23

    Jan

JBHT

J.B. Hunt

$114.20

-1.63 (-1.41%)

15:09
01/22/20
01/22
15:09
01/22/20
15:09
Hot Stocks
J.B. Hunt raises quarterly dividend to 27c from 26c per share »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

TXN

Texas Instruments

$133.23

2.38 (1.82%)

15:04
01/22/20
01/22
15:04
01/22/20
15:04
Options
Texas Instruments options imply 7.4% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

QSR

Restaurant Brands

$65.41

0.085 (0.13%)

, TAST

Carrols Restaurant

$5.01

-0.1 (-1.96%)

14:55
01/22/20
01/22
14:55
01/22/20
14:55
Periodicals
Burger King cutting Impossible Whopper price as sales slow, Bloomberg says »

Burger King, a Restaurant…

QSR

Restaurant Brands

$65.41

0.085 (0.13%)

TAST

Carrols Restaurant

$5.01

-0.1 (-1.96%)

BYND

Beyond Meat

$124.60

-4.64 (-3.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXPR

Express

$4.96

0.81 (19.52%)

14:51
01/22/20
01/22
14:51
01/22/20
14:51
Recommendations
Express analyst commentary  »

Wedbush…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

BYND

Beyond Meat

$125.41

-3.83 (-2.96%)

, QSR

Restaurant Brands

$65.43

0.105 (0.16%)

14:51
01/22/20
01/22
14:51
01/22/20
14:51
Periodicals
Burger King cutting Impossible Whopper price as sales slow, Bloomberg says »

Shares of Beyond Meat,…

BYND

Beyond Meat

$125.41

-3.83 (-2.96%)

QSR

Restaurant Brands

$65.43

0.105 (0.16%)

TAST

Carrols Restaurant

$5.02

-0.09 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMI

Kinder Morgan

$21.04

0.11 (0.53%)

14:49
01/22/20
01/22
14:49
01/22/20
14:49
Options
Kinder Morgan options imply 2.9% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 29

    Jan

VZ

Verizon

$60.68

0.36 (0.60%)

, GOOG

Alphabet

$1,493.50

8.58 (0.58%)

14:43
01/22/20
01/22
14:43
01/22/20
14:43
Hot Stocks
Verizon partners with Google Stadia for cloud gaming »

"It's no…

VZ

Verizon

$60.68

0.36 (0.60%)

GOOG

Alphabet

$1,493.50

8.58 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 03

    Feb

MDC

M.D.C. Holdings

$43.74

0.51 (1.18%)

14:39
01/22/20
01/22
14:39
01/22/20
14:39
Hot Stocks
Richmond American Homes plans to acquire 1,000 sites at Aurora Highlands »

Richmond American Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

CHCO

City Holding

$80.65

0.14 (0.17%)

14:32
01/22/20
01/22
14:32
01/22/20
14:32
Hot Stocks
City Holding announces pre-tax gain of $17.8M on sale of Visa Class B shares »

City Holding Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$66.49

0.19 (0.29%)

14:31
01/22/20
01/22
14:31
01/22/20
14:31
Hot Stocks
Comerica names Melinda Chausse chief credit officer »

Comerica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Feb

AAOI

Applied Optoelectronics

$14.23

0.51 (3.72%)

14:25
01/22/20
01/22
14:25
01/22/20
14:25
Options
Applied Optoelectronics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PG

Procter & Gamble

$126.65

0.54 (0.43%)

, UNP

Union Pacific

$181.23

-1.27 (-0.70%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PG

Procter & Gamble

$126.65

0.54 (0.43%)

UNP

Union Pacific

$181.23

-1.27 (-0.70%)

KMB

Kimberly-Clark

$145.50

0.91 (0.63%)

VFC

VF Corp.

$95.12

0.49 (0.52%)

LUV

Southwest

$53.64

0.1 (0.19%)

MTB

M&T Bank

$162.54

1.655 (1.03%)

KEY

KeyCorp

$19.61

0.11 (0.56%)

HBAN

Huntington Bancshares

$14.84

0.22 (1.51%)

AAL

American Airlines

$27.50

0.29 (1.07%)

JBLU

JetBlue

$19.90

0.81 (4.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 17

    Feb

  • 04

    Mar

TXN

Texas Instruments

$133.66

2.81 (2.15%)

, KMI

Kinder Morgan

$21.05

0.12 (0.57%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$133.66

2.81 (2.15%)

KMI

Kinder Morgan

$21.05

0.12 (0.57%)

CTXS

Citrix

$119.46

1.67 (1.42%)

TER

Teradyne

$73.17

1.64 (2.29%)

PTC

PTC

$79.86

0.93 (1.18%)

STLD

Steel Dynamics

$32.05

0.14 (0.44%)

SLM

Sallie Mae

$9.15

0.31 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

XOM

Exxon Mobil

$67.01

-0.58 (-0.86%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Periodicals
Exxon Mobil set to kick off U.K., Germany asset sales, Bloomberg says »

Exxon Mobil intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

CHEOY

Cochlear

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/22/20
01/22
14:16
01/22/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPG

Simon Property

$146.15

-2.96 (-1.99%)

14:15
01/22/20
01/22
14:15
01/22/20
14:15
Options
Simon Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

, PKX

Posco

$51.39

-0.15 (-0.29%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
On The Fly
FuelCell plunges on bigger than expected loss, revenue miss »

Shares of FuelCell (FCEL)…

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

PKX

Posco

$51.39

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

NK

NantKwest

$5.94

-0.32 (-5.11%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
Hot Stocks
Breaking Hot Stocks news story on NantKwest 

NantKwest trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$5.90

-0.36 (-5.75%)

14:09
01/22/20
01/22
14:09
01/22/20
14:09
Hot Stocks
Breaking Hot Stocks news story on NantKwest »

NantKwest trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.